4//SEC Filing
D'Silva Andrew J. 4
Accession 0001628280-25-058409
CIK 0001448431other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 10:07 AM ET
Size
5.2 KB
Accession
0001628280-25-058409
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
D'Silva Andrew J.
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-12-19$13.51/sh−703$9,498→ 44,735 total
Footnotes (1)
- [F1]These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0002083717
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 10:07 AM ET
- Size
- 5.2 KB